Exponent (EXPO) CEO exercises 7,872 options, holds 115,129 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Exponent Inc. CEO Catherine Corrigan exercised stock options to acquire 7,872 shares of common stock. The options were exercised at an effective price of $25.405 per share, converting an incentive stock option grant into common shares.
Following this exercise, Corrigan directly holds 115,129 shares of Exponent common stock. The derivative position tied to this option grant was reduced to zero, and there was no reported same-day sale, indicating an exercise-and-hold transaction. A footnote notes the stock option became exercisable in four equal annual installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
7,872 shares exercised/converted
Mixed
2 txns
Insider
Corrigan Catherine
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Incentive Stock Option (right to buy) | 7,872 | $0.00 | -- |
| Exercise | Common Stock | 7,872 | $25.405 | $200K |
Holdings After Transaction:
Incentive Stock Option (right to buy) — 0 shares (Direct, null);
Common Stock — 115,129 shares (Direct, null)
Footnotes (1)
- The stock option becomes exercisable in four equal annual installments. Not applicable.
Key Figures
Shares exercised: 7,872 shares
Exercise price: $25.405 per share
Shares held after: 115,129 shares
+2 more
5 metrics
Shares exercised
7,872 shares
Common stock acquired via option exercise on June 25, 2026
Exercise price
$25.405 per share
Exercise price of incentive stock option converted to common stock
Shares held after
115,129 shares
Direct common stock holdings following the reported transaction
Option shares converted
7,872 shares
Incentive stock option (right to buy) converted into common stock
Option expiration
July 29, 2026
Expiration date of the exercised incentive stock option grant
Key Terms
Incentive Stock Option, Exercise or conversion of derivative security, Common Stock, stock option
4 terms
Incentive Stock Option financial
"security_title: "Incentive Stock Option (right to buy)""
An incentive stock option is a type of employee benefit that gives a worker the right to buy company shares at a fixed price, with special tax advantages if the employee holds the shares for a required period. Think of it as a coupon to buy future shares at today’s price that can result in lower tax on the gain. Investors care because ISOs can dilute share count, align staff incentives with the stock price, and affect company compensation costs and the timing of potential share sales.
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
stock option financial
"The stock option becomes exercisable in four equal annual installments."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
What did Exponent (EXPO) CEO Catherine Corrigan report on this Form 4?
Catherine Corrigan reported exercising incentive stock options to acquire 7,872 shares of Exponent common stock. The transaction converted a derivative position into shares and did not include any same-day sale, indicating an exercise-and-hold pattern for this grant.
At what price were the Exponent (EXPO) stock options exercised?
The incentive stock options were exercised at an effective exercise price of $25.405 per share. This price reflects the conversion or exercise price specified for the derivative security when it was converted into 7,872 shares of Exponent common stock on the transaction date.
What happened to the CEO’s incentive stock option position at Exponent (EXPO)?
The incentive stock option for 7,872 shares was fully exercised, leaving zero derivative shares remaining from that grant. The option carried a $25.405 exercise price and an expiration date of July 29, 2026, but is now fully converted into common stock.
How did the Exponent (EXPO) stock option grant to the CEO vest?
A footnote states that the stock option became exercisable in four equal annual installments. This means the grant vested gradually over four years before being fully exercisable, allowing Catherine Corrigan to convert the entire 7,872-share option into common stock.